This work is licensed under the Creative Commons Attribution 4.0 International License.
Sharma S, Zapatero-Rodriguez J, O’Kennedy R. Prostate cancer diagnostics: Clinical challenges and the ongoing need for disruptive and effective diagnostic tools. Biotechnology Advances. 2017;35(2):135-49. DOI: 10.1016/j.biotechadv.2016.11.009Search in Google Scholar
Hanahan D. Hallmarks of cancer: new dimensions. Cancer discovery. 2022;12(1):31-46. DOI: 10.1158/2159-8290.CD-21-1059Search in Google Scholar
Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology. 2012;60(1):199-215. DOI: 10.1111/j.1365-2559.2011.04033.xSearch in Google Scholar
Kurowska P, Mlyczyńska E, Dawid M, Jurek M, Klimczyk D, Dupont J, et al. Vaspin (SERPINA12) expression and function in endocrine cells. Cells. 2021;10(7):1710. DOI: 10.3390/cells10071710Search in Google Scholar
Zhang P, Wang G, Gui Y, Guo Z, Ren R, Sun Y, et al. Serum vaspin as a predictor of severity and prognosis in acute ischemic stroke patients. Nutritional Neuroscience. 2022;25(4):737-45. DOI: 10.1080/1028415X.2020.1806191Search in Google Scholar
Agarwal S, Desai S. Vaspin and its relation to cancer. World Academy of Sciences Journal. 2021;3(6):1-6. DOI: 10.3892/wasj.2021.129Search in Google Scholar
Si H, Zhang Y, Song Y, Li L. Overexpression of adrenomedullin protects mesenchymal stem cells against hypoxia and serum deprivationinduced apoptosis via the Akt/GSK3β and Bcl2 signaling pathways. International journal of molecular medicine. 2018;41(6):3342-52. DOI: 10.3892/ijmm.2018.3533Search in Google Scholar
Treeck O, Buechler C, Ortmann O. Chemerin and cancer. International journal of molecular sciences. 2019;20(15):3750. DOI: 10.3390/ijms20153750Search in Google Scholar
Groblewska M, Litman-Zawadzka A, Mroczko B. The role of selected chemokines and their receptors in the development of gliomas. International journal of molecular sciences. 2020;21(10):3704. DOI: 10.3390/ijms21103704Search in Google Scholar
Jaikanth C, Gurumurthy P, Cherian K, Indhumathi T. Emergence of omentin as a pleiotropic adipocytokine. Experimental and clinical endocrinology & diabetes. 2013;121(07):377-83. DOI: 10.1055/s-0033-1345123Search in Google Scholar
Uyeturk U, Sarıcı H, Kın Tekce B, Eroglu M, Kemahlı E, Uyeturk U, et al. Serum omentin level in patients with prostate cancer. Medical oncology. 2014;31:1-5. DOI: 10.1007/s12032-014-0923-6Search in Google Scholar
Li B. Effects of NFκB Inhibition on Macrophage-adipocytes-prostate Cancer Cell Crosstalk: University of Sheffield; 2021.Search in Google Scholar
Wang W, Nag SA, Zhang R. Targeting the NFκB signaling pathways for breast cancer prevention and therapy. Current medicinal chemistry. 2015;22(2):264-89. DOI: 10.2174/092986732166614 1106124315Search in Google Scholar
Davidsson S, Carlsson J, Greenberg L, Wijkander J, Söderquist B, Erlandsson A. Cutibacterium acnes induces the expression of immunosuppressive genes in macrophages and is associated with an increase of regulatory T-cells in prostate cancer. Microbiology spectrum. 2021;9(3):e01497-21. DOI: 10.1128/spectrum.01497-21Search in Google Scholar
Kumar A, Khani AT, Ortiz AS, Swaminathan S. GM-CSF: A double-edged sword in cancer immunotherapy. Frontiers in Immunology. 2022;13. DOI: 10.3389/fimmu.2022.901277Search in Google Scholar
Rourke J, Dranse H, Sinal C. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obesity Reviews. 2013;14(3):245-62. DOI: 10.1111/obr.12009Search in Google Scholar
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nature reviews immunology. 2011;11(2):85-97. DOI: 10.1038/nri2921Search in Google Scholar
Kaur J, Adya R, Tan BK, Chen J, Randeva HS. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochemical and biophysical research communications. 2010;391(4):1762-8. DOI: 10.1016/j.bbrc.2009.12.150Search in Google Scholar
Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer research. 2008;68(1):329-37. DOI: 10.1158/0008-5472. CAN-07-2946Search in Google Scholar
Booth A, Magnuson A, Fouts J, Foster M. Adipose tissue, obesity and adipokines: role in cancer promotion. Hormone molecular biology and clinical investigation. 2015;21(1):57-74. DOI: 10.1515/hmbci-2014-0037Search in Google Scholar
Erdogan S, Yilmaz FM, Yazici O, Yozgat A, Sezer S, Ozdemir N, et al. Inflammation and chemerin in colorectal cancer. Tumor Biology. 2016;37:6337-42. DOI: 10.1007/s13277-015-4483-ySearch in Google Scholar
Wang C, Wu WK, Liu X, To K-F, Chen GG, Yu J, et al. Increased serum chemerin level promotes cellular invasiveness in gastric cancer: a clinical and experimental study. Peptides. 2014;51:131-8. DOI: 10.1016/j.peptides.2013.10.009Search in Google Scholar
Fazeli MS, Dashti H, Akbarzadeh S, Assadi M, Aminian A, Keramati MR, et al. Circulating levels of novel adipocytokines in patients with colorectal cancer. Cytokine. 2013;62(1):81-5. DOI: 10.1016/j. cyto.2013.02.012Search in Google Scholar
Wong RS. Apoptosis in cancer: from pathogenesis to treatment. Journal of experimental & clinical cancer research. 2011;30(1):1-14. DOI: 10.1186/1756-9966-30-87Search in Google Scholar
Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA. Portrait of the PI3K/AKT pathway in colorectal cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2015;1855(1):104-21. DOI: 10.1016/j.bbcan.2014.09.008Search in Google Scholar
Zhao X, Zhang Y, Deng L, Wang Y, Li Y, Chen M. The association between Chinese patients’ elevated omentin-1 levels, their clinicopathological features, and the risk of colorectal cancer. International journal of clinical and experimental pathology. 2019;12(6):2264.Search in Google Scholar
Washimi K, Yokose T, Yamashita M, Kageyama T, Suzuki K, Yoshihara M, et al. Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells. PLoS One. 2012;7(7):e39889. DOI: 10.1371/journal.pone.0039889Search in Google Scholar
Karabulut S, Afsar CU, Karabulut M, Alis H, Bozkurt MA, Aydogan F, et al. Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma. BBA clinical. 2016;6:138-42. DOI: 10.1016/j.bbacli.2016.10.002Search in Google Scholar
Zhou L, He W, Wang W, Zhou D. Altered circulating levels of adipokine omentin-1 in patients with prostate cancer. OncoTargets and therapy. 2019;12:3313. DOI: 10.2147/OTT. S197507Search in Google Scholar
Fryczkowski M, Bułdak R, Hejmo T, Kukla M, Żwirska-Korczala K. Circulating levels of omentin, leptin, VEGF, and HGF and their clinical relevance with PSA marker in prostate cancer. Disease markers. 2018;2018. DOI: 10.1155/2018/3852401Search in Google Scholar
Zhang Y-Y, Zhou L-M. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. European journal of pharmacology. 2013;698(1-3):137-44. DOI: 10.1016/j. ejphar.2012.11.016Search in Google Scholar
Ji H, Wan L, Zhang Q, Chen M, Zhao X. The effect of omentin-1 on the proliferation and apoptosis of colon cancer stem cells and the potential mechanism. J buon. 2019;24(1):91-8.Search in Google Scholar
Zhang Y, Zhao X, Chen M. Autocrine action of adipokine omentin1 in the SW480 colon cancer cell line. Oncology Letters. 2020;19(1):892-8. DOI: 10.3892/ol.2019.11131Search in Google Scholar
Borowski A, Siemińska L. Serum omentin levels in patients with prostate cancer and associations with sex steroids and metabolic syndrome. Journal of Clinical Medicine. 2020;9(4):1179. DOI: 10.3390/jcm9041179Search in Google Scholar
Lin S, Li X, Zhang J, Zhang Y. Omentin-1: Protective impact on ischemic stroke via ameliorating atherosclerosis. Clinica Chimica Acta. 2021;517:31-40. DOI: 10.1016/j.cca.2021.02.004Search in Google Scholar
Pin E, Stratton S, Belluco C, Liotta L, Nagle R, Hodge KA, et al. A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray. Molecular Oncology. 2016;10(10):1585-94. DOI: 10.1016/j. molonc.2016.09.007Search in Google Scholar
Neveu B, Moreel X, Deschênes-Rompré M-P, Bergeron A, LaRue H, Ayari C, et al. IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressiveness. Research and reports in urology. 2014:27-34. DOI: 10.2147/RRU.S58643Search in Google Scholar
Chaiswing L, Weiss HL, Jayswal RD, Clair DKS, Kyprianou N. Profiles of radioresistance mechanisms in prostate cancer. Critical Reviews™ in Oncogenesis. 2018;23(1-2). DOI: 10.1615/CritRevOncog.2018025946Search in Google Scholar
Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, et al. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study. American journal of epidemiology. 2013;177(1):3-13. DOI: 10.1093/aje/kws359Search in Google Scholar
Yencilek F, Yildirim A, Yilmaz SG, Altinkilic EM, Dalan AB, Bastug Y, et al. Investigation of interleukin-1β polymorphisms in prostate cancer. Anticancer Research. 2015;35(11):6057-61.Search in Google Scholar
Thibodeau S, French A, McDonnell S, Cheville J, Middha S, Tillmans L, et al. Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set. Nature communications. 2015;6(1):8653. DOI: 10.1038/ncomms9653Search in Google Scholar
Park M-J, Hyun M-H, Yang J-P, Yoon J-M, Park S. Effects of the interleukin-1β-511 C/T gene polymorphism on the risk of gastric cancer in the context of the relationship between race and H. pylori infection: a meta-analysis of 20,000 subjects. Molecular biology reports. 2015;42:119-34. DOI: 10.1007/s11033-014-3748-7Search in Google Scholar
Wang J, Shi Y, Wang G, Dong S, Yang D, Zuo X. The association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancer. Molecular Genetics & Genomic Medicine. 2019;7(8):e804. DOI: 10.1002/mgg3.804Search in Google Scholar
Urquidi V, Kim J, Chang M, Dai Y, Rosser CJ, Goodison S. CCL18 in a multiplex urine-based assay for the detection of bladder cancer. PLoS One. 2012;7(5):e37797. DOI: 10.1371/journal. pone.0037797Search in Google Scholar
Sun Z, Du C, Xu P, Miao C. Surgical trauma-induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression. Journal of cellular physiology. 2019;234(4):4608-16. DOI: 10.1002/jcp.27245Search in Google Scholar
Wang L, Wang Y-x, Zhang D-z, Fang X-j, Sun P-s, Xue H-c. Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway. Biomedicine & Pharmacotherapy. 2016;78:301-7. DOI: 10.1016/j.biopha.2016.01.028Search in Google Scholar
Wang Q, Tang Y, Yu H, Yin Q, Li M, Shi L, et al. CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway. Molecular Carcinogenesis. 2016;55(11):1688-99.. DOI: 10.1002/mc.22419Search in Google Scholar
Hou X, Zhang Y, Qiao H. CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-κB signaling pathway. Tumor Biology. 2016;37:641-51. DOI: 10.1007/s13277-015-3825-0Search in Google Scholar
Meng F, Li W, Li C, Gao Z, Guo K, Song S. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma. International journal of oncology. 2015;46(3):1109-20. DOI: 10.3892/ijo.2014.2794Search in Google Scholar
Su Y, Zhou Y, Sun Y-j, Wang Y-L, Yin J-y, Huang Y-j, et al. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1. Journal of Molecular Medicine. 2019;97:49-61. DOI: 10.1007/s00109-018-1711-0Search in Google Scholar
She L, Qin Y, Wang J, Liu C, Zhu G, Li G, et al. Tumor-associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck. Cancer cell international. 2018;18(1):1-14. DOI: 10.1186/s12935-018-0620-1Search in Google Scholar
Schmid S, Csanadi A, Kozhuharov N, Tchudjin M, Kayser C, Rawluk J, et al. CC-chemokine ligand 18 is an independent prognostic marker in lymph node-positive non-small cell lung cancer. Anticancer Research. 2018;38(7):3913-8. DOI: 10.21873/anticanres.12676Search in Google Scholar
Chen G, Liang Y-x, Zhu J-g, Fu X, Chen Y-f, Mo R-j, et al. CC chemokine ligand 18 correlates with malignant progression of prostate cancer. BioMed research international. 2014;2014. . DOI: 10.1155/2014/230183Search in Google Scholar
Hong I-S. Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types. Experimental & molecular medicine. 2016;48(7):e242-e. DOI: 10.1038/emm.2016.64Search in Google Scholar
Rho CR, Park M-y, Kang S. Effects of granulocyte-macrophage colony-stimulating (GM-CSF) factor on corneal epithelial cells in corneal wound healing model. PLoS One. 2015;10(9):e0138020. DOI: 10.1371/journal.pone.0138020Search in Google Scholar
Urdinguio RG, Fernandez AF, Moncada-Pazos A, Huidobro C, Rodriguez RM, Ferrero C, et al. Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal TumorsAntitumor Activity of GM-CSF in Colorectal Tumors. Cancer research. 2013;73(1):395-405. DOI: 10.1158/0008-5472.CAN-12-0806Search in Google Scholar
Ardekani MTF, Malekzadeh M, Hosseini SV, Bordbar E, Doroudchi M, Ghaderi A. Evaluation of pre-treatment serum levels of IL-7 and GM-CSF in colorectal cancer patients. International journal of molecular and cellular medicine. 2014;3(1):27.Search in Google Scholar
Zemanová M, Staňková B, Ušiakova Z, Tvrzická E, Pazdro A, Petruželka L, et al. Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: A pilot study. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2014;20:2351. DOI: 10.12659/MSM.891088Search in Google Scholar
Gartung A, Yang J, Sukhatme VP, Bielenberg DR, Fernandes D, Chang J, et al. Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor. Proceedings of the National Academy of Sciences. 2019;116(5):1698-703. DOI: 10.1073/pnas.1803999116Search in Google Scholar
Haak VM, Huang S, Panigrahy D. Debris-stimulated tumor growth: a Pandora’s box? Cancer and Metastasis Reviews. 2021:1-11. DOI: 10.1007/s10555-021-09998-8Search in Google Scholar
Mendoza-Reinoso V, Baek DY, Kurutz A, Rubin JR, Koh AJ, McCauley LK, et al. Unique pro-inflammatory response of macrophages during apoptotic cancer cell clearance. Cells. 2020;9(2):429. DOI: 10.3390/cells9020429Search in Google Scholar
Morana O, Wood W, Gregory CD. The apoptosis paradox in cancer. International Journal of Molecular Sciences. 2022;23(3):1328. DOI: 10.3390/ijms23031328Search in Google Scholar
Middleton JD, Fehlman J, Sivakumar S, Stover DG, Hai T. Stress-inducible gene Atf3 dictates a dichotomous macrophage activity in chemotherapy-enhanced lung colonization. International journal of molecular sciences. 2021;22(14):7356. DOI: 10.3390/ijms22147356Search in Google Scholar
Peng S, Fu Y. FYN: emerging biological roles and potential therapeutic targets in cancer. Journal of Translational Medicine. 2023;21(1):84. DOI: 10.1186/s12967-023-03930-0Search in Google Scholar
Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin GV, Shurin MR, et al. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes withanti-PD-1 for tumor abrogation. Proceedings of the National Academy of Sciences. 2019;116(4):1361-9. DOI: 10.1073/pnas.1812266115Search in Google Scholar
Ghahartars M, Abtahi S, Zeinali Z, Fattahi MJ, Ghaderi A. Investigation of TNF-α and IL-6 levels in the sera of non-melanoma skin cancer patients. Iranian biomedical journal. 2021;25(2):88. DOI: 10.29252/ibj.25.2.88Search in Google Scholar
Fletcher R, Tong J, Risnik D, Leibowitz BJ, Wang Y-J, Concha-Benavente F, et al. Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis. Oncogene. 2021;40(11):2035-50. DOI: 10.1038/s41388-021-01687-8Search in Google Scholar